Bitter taste perception is initiated by TAS2R receptors, which respond to agonists by triggering depolarization of taste bud cells. Mutations in TAS2Rs are known to affect taste phenotypes by altering receptor function. Evidence that TAS2Rs overlap in ligand specificity suggests that they may also contribute joint effects. To explore this aspect of gustation, we examined bitter perception of saccharin and acesulfame K, widely used artificial sweeteners with aversive aftertastes. Both substances are agonists of TAS2R31 and -43, which belong to a five-member subfamily (TAS2R30 -46) responsive to a diverse constellation of compounds. We analyzed sequence variation and linkage structure in the ∼140 kb genomic region encoding TAS2R30 -46, taste responses to the two sweeteners in subjects, and functional characteristics of receptor alleles. Whole-gene sequences from TAS2R30 -46 in 60 Caucasian subjects revealed extensive diversity including 34 missense mutations, two nonsense mutations and high-frequency copy-number variants. Thirty markers, including non-synonymous variants in all five genes, were associated (P < 0.001) with responses to saccharin and acesulfame K. However, linkage disequilibrium (LD) in the region was high (D ′ , r 2 > 0.95). Haplotype analyses revealed that most associations were spurious, arising from LD with variants in TAS2R31. In vitro assays confirmed the functional importance of four TAS2R31 mutations, which had independent effects on receptor response. The existence of high LD spanning functionally distinct TAS2R loci predicts that bitter taste responses to many compounds will be strongly correlated even when they are mediated by different genes. Integrative approaches combining phenotypic, genetic and functional analysis will be essential in dissecting these complex relationships.
INTRODUCTION
Bitter taste perception is thought to act as a 'toxin detector' that warns of the presence of noxious compounds in foods, especially plant toxins such as alkaloids, which are often bitter (1) . By signaling the presence of toxins, bitter taste provides protection against overexposure. In humans, this role has been reduced by technological innovations, such as cooking and agriculture. However, bitter perception continues to be an important determinant of health through its effects on behaviors, such as diet choice (2 -6) , alcohol consumption (7) and smoking habits (8, 9) . Variation in bitter taste sensitivity is substantial, and is associated with health predictors, such as vegetable intake (2), obesity (10) and possibly susceptibility to certain cancers (11) . A key goal in taste psychophysics is to understand the mechanistic underpinnings of this variation.
Bitter taste responses in humans are mediated at their earliest stages by bitter taste receptors, a series of 25 G proteincoupled receptors encoded by the TAS2R gene family (12) (13) (14) . TAS2Rs are expressed in taste buds, on the surface of the tongue and soft palate, where they are poised to respond to bitter compounds entering the mouth (12) . When exposed to agonists, they trigger a transductional cascade that culminates in generation of a neural signal leading to perception (15) .
Mounting evidence suggests that TAS2Rs play physiological roles beyond taste perception, as well. Cells in the gut, nose and bronchi express all major components of the bitter taste transduction pathway and respond to agonists via TAS2R-mediated signaling, suggesting that TAS2Rs play generalized roles in environmental response (16) (17) (18) .
Because they play a critical role in initiating transduction, mutational variation in TAS2Rs can have profound phenotypic effects (19) . For instance, alleles of TAS2R38 account for .50% of phenotypic variance in threshold perception of phenylthiocarbamide (PTC), which ranges up to 10 000-fold among individuals (20, 21) . Large-scale screens have revealed that TAS2Rs as a group are capable of responding to a broad constellation of structurally diverse compounds, suggesting that individuals likely vary in ability to perceive numerous bitter substances (22) . Further, TAS2Rs exhibit extensive overlap in agonist specificity (22) . For instance, 15 receptors are known to respond to diphenidol (22) . Thus, bitter taste responses are in many cases not a simple one-to-one function of interaction between agonists and their receptors, but a function of interactions between agonists and multiple receptors simultaneously. This, together with their potentially broad biological role, suggests that allelic diversity in TAS2Rs could have far-reaching phenotypic consequences.
A striking characteristic of certain artificial sweeteners, including saccharin and acesulfame K, is that in addition to being perceived as intensely sweet by most individuals, they are often described as having a bitter off-taste (23) (24) (25) (26) . This property arises from agonistic interactions with TAS2R31 and TAS2R43, both of which respond to saccharin and acesulfame K at low concentrations (22, 27, 28) . In addition, TAS2R31 and -43 harbor allelic variation that predicts both the perceived bitterness of saccharin in subjects and functional response in cell-based assays (29) . TAS2R31 and -43 are encoded by two members of a TAS2R subfamily residing in a 140 kb region at chromosome 12p13 that includes three additional loci: TAS2R30, -45 and -46 ( Fig. 1) (30) . It is not known whether any alleles of TAS2R30, -45 or -46 are responsive to saccharin or acesulfame K; however, their most common alleles exhibit sensitivity to a range of natural and synthetic agonists overlapping with those of TAS2R31 and -43, indicating that overlap with respect to saccharin and acesulfame K is likely (Fig. 2) . Further, the genomic proximity of the loci encoding TAS2R30 -46 suggests that phenotypic effects arising from mutations in these receptors, including previously reported effects arising from TAS2R31 and -43, 
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should be correlated. To investigate the joint roles of the TAS2R30 -46 subfamily in shaping perception of artificial sweeteners, we examined associations between variation in the perceived bitterness of saccharin and acesulfame K, genetic and genomic variation in TAS2R30 -46 and functional variation in receptor alleles.
RESULTS

Taste responses
Threshold perception concentrations of saccharin and acesulfame K estimated using a modified Harris -Kalmus protocol revealed extensive variation. Subjects ranged 64-fold in threshold response to both compounds, with consistent measures across replicates (r 2 ¼ 0.93 and 0.92, respectively) ( Fig. 3) . Further, responses to the two compounds were strongly correlated (r 2 ¼ 0.93). The ranges of response to saccharin and acesulfame K were substantially greater than those of two control compounds, salicin and denatonium benzoate, which varied 8 -16-fold, with cross-replicate r 2 values of 0.75 and 0.86. In addition, the distributions of threshold responses to saccharin and acesulfame K were broad and slightly bimodal while those of salicin and denatonium benzoate were narrow and unimodal (Fig. 3) . The threshold ranges of all three compounds differed from those reported for the well-known bitter marker compound, PTC, which elicits responses over a 10 000-fold range and has a strongly bimodal distribution (31) .
Genotypes
Whole-gene sequences obtained from TAS2R30 -46 revealed that our subjects collectively harbored 42 single-nucleotide polymorphisms (SNPs) distributed across all five genes (Fig. 4) . In addition, a small in-frame (18 bp) deletion was present in TAS2R43. Strikingly, 86% of SNPs (36 of 42) were missense or nonsense mutations. Thirty-four encoded amino acid substitutions. Two, TAS2R45-A900G/X300W and TAS2R46-G749A/W250X, encoded premature stop codons, with the TAS2R45 mutation predicted to truncate the encoded receptor by four amino acids and the TAS2R46 mutation predicted to elongate the encoded protein to roughly three-quarters its normal length. This level of variation is far greater than that observed at most loci in humans (32) . However, it is similar to levels reported for other TAS2Rs, which are substantially more diverse than most human genes. For instance, the frequency of non- Figure 3 . Threshold responses and chemical structures. Threshold responses were determined for four compounds: saccharin, acesulfame K, salicin and denatonium benzoate. Saccharin and acesulfame K are structurally similar sulfonamides used as artificial sweeteners. Salicin and denatonium benzoate, used as control substances, are structurally unrelated. For each subject, four replicate estimates were obtained and averaged. In each graph, bar height indicates the number of subjects with the given mean threshold. Threshold distributions for saccharin and acesulfame K exhibited evidence of bimodality, while those of salicin and denatonium benzoate were unimodal. Curves indicate log-normal fitted distributions.
synonymous SNPs in our sample, 86%, is high compared with other human genes, but is similar to the 74% observed by Kim et al. (33) in a survey of variation across the TAS2R family as a whole.
Copy-number variation
In a previous study, Pronin et al. (29) inferred the presence of polymorphic whole-gene deletions of TAS2R43 and -45 on the basis of persistent technical problems with polymerase chain reaction (PCR) amplification. However, individual genotypes with respect to the deletions, which are essential for analyzing genotype -phenotype associations, remained unresolved. Initial PCR and sequence data in our sample were consistent with the presence of the deletions identified by Pronin et al. (29) . PCR failed to amplify TAS2R43 in .25% of our sample, even when primers were redesigned and relocated several times (Fig. 5A) . TAS2R45 failed to amplify in a smaller number of samples. In addition, tests for HardyWeinberg equilibrium revealed a highly significant excess of homozygosity at both TAS2R43 and TAS2R45. For instance, the C and G alleles at TAS2R43-C104G had allele frequencies of 0.72 and 0.28, respectively, but the genotype frequencies were 0.64, 0.16 and 0.20 for CC, CG and GG, respectively (x 2 ¼ 16.31, d.f. ¼ 2; P , 0.001) (Fig. 5D) .
High rates of PCR failure and departures from HardyWeinberg equilibrium are both consistent with the presence of high-frequency deletion (D) alleles. High rates of PCR failure are explained by the fact that PCR priming sites are 
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Human Molecular Genetics, 2011, Vol. 20, No. 17 completely absent from subjects homozygous for the deletion; thus, no PCR product is produced and the reactions appear to have failed. Excess homozygosity is explained because DNA sequences from subjects heterozygous with respect to the deletion come from the amplified allele only; thus, these individuals falsely appear to be homozygous at every nucleotide position. This results in departure from Hardy -Weinberg equilibrium, exactly the pattern we observed. Copy-number assays targeting each of the five genes in our study confirmed that deletion alleles are present at both TAS2R43 and TAS2R45. Assays targeting TAS2R43 revealed 16 subjects with a copy number of zero (i.e. homozygous for the deleted allele), 28 with a copy number of one and 16 with a copy number of two (Fig. 5B) . Thus, the frequency of the TAS2R43-D allele was 0.50. At TAS2R45, the number of subjects with copy numbers of zero, one and two were 2, 11 and 30, with the TAS2R45-D allele having a frequency of 0.15. Neither PCR dropouts nor excess homozygosity were observed at TAS2R30, -31 or -46, and copy-number assays targeting those loci indicated that all subjects had a copy number of two, suggesting that deletion alleles are either absent or present at very low frequencies.
DNA sequence and copy-number variation were mutually consistent at both TAS2R43 and -45. As expected: (i) all subjects that had previously failed to amplify by PCR were found to have copy numbers of zero (i.e. were homozygous for the deleted allele), (ii) no samples successfully amplified using PCR were found to have a copy number of zero, (iii) no samples with a copy number of one (i.e. heterozygous with respect to the deleted allele) were heterozygous at any nucleotide position, and (iv) all samples heterozygous at any nucleotide position were found to have a copy number of two (i.e. were homozygous for the non-deleted allele). Further, while genotypes based on sequence chromatogram data alone were far out of Hardy -Weinberg equilibrium, genotypes based on combined data were in near-perfect equilibrium (Fig. 5D ).
Allele and genotype frequencies based on the combined copy-number and genotype data for TAS2R43 and -45 differed radically from estimates based sequence data alone (Fig. 5D ). For instance, when the presence of TAS2R43-D was ignored, the estimated frequency of the C allele at nucleotide position 104 of the gene was 0.72. When the copy-number data were taken into account, the frequency dropped more than 50% to 0.35 ( Fig. 5D ). Genotype frequencies were even more strongly affected. For instance, the estimated frequency of the CC genotype was 0.64 when TAS2R43-D was not taken into account, . Copy-number calls were determined using cutoffs at raw scores of 0.5 and 1.5 estimated copies. At TAS2R43, the frequency of the deleted allele (TAS2R43-H△) was 0.50. At TAS2R45, the frequency of the deleted allele (TAS2R45-H△) was 0.15. qPCR assays targeted at TAS2R30, -31 and -46 showed no evidence of copy-number variation. (C) Sequencing chromatograms alone were not sufficient to distinguish subjects homozygous with respect to a particular SNP from subjects carrying one copy of the SNP and one copy of the deleted allele. Information on copy number resolved the ambiguity by separating genotypes into those who were true homozygotes (which had a copy number of two) from those carrying one copy of the SNP allele and one deleted allele (which had a copy number of one). All SNP heterozygotes had a copy number of two. (D) Genotype and allele frequencies at a representative SNP (TAS2R43-C104G) were strongly affected by the incorporation of copy-number data into base calls. Uncorrected genotype and allele frequencies, based on DNA sequence chromatograms alone, erroneously conflated subjects homozygous for a particular SNP allele with those carrying a single copy of the allele and a deleted allele (e.g. CC could not be distinguished from C△). TAS2R43 failed to amplify at all in many subjects. These effects resulted in a major excess of homozygosity, which was reflected in a highly significant (P , 0.001) departure from Hardy-Weinberg equilibrium. Corrected genotype and allele frequencies, determined by combining sequence and copy-number data, correctly distinguished subjects homozygous for a particular SNP allele (e.g. CC) from those carrying a single copy of the allele and a deleted allele (e.g. C△), as well as △ homozygotes, bringing the sample into Hardy-Weinberg equilibrium. and dropped more than 75%, to 0.12, when corrected. These results illustrate the critical importance of incorporating information on copy-number variation into genotype calls: failure to do so can lead to major errors in allele and genotype frequency estimates, and likely detection of genotype -phenotype associations.
Linkage disequilibrium (LD) and haplotypes
Measures of linkage disequilibrium (LD) revealed extensive correlations among sites across the TAS2R30 -46 region. D ′ , a normalized measure that provides information about the extent to which recombination has generated diversity in a region, exceeded 0.95 for nearly all pairs of sites. r 2 , a raw measure of correlations among markers, exceeded 0.95 for pairs of sites .100 kb apart (Fig. 6A) . High levels of LD indicate that SNPs in a region are co-segregating, which can result in spurious associations when non-functional variants are linked with truly functional variants nearby. Determination of haplotypes confirmed that genetic variation in the TAS2R30 -46 region is highly structured by LD. Within-gene analyses identified 5, 7, 6, 5 and 3 haplotypes in TAS2R30, -31, -43, -45 and -46, respectively, including the D alleles at TAS2R43 and TAS2R45 (Fig. 4) . As with individual SNPs, many haplotypes were found at high frequencies. All five loci harbored multiple haplotypes, and every locus harbored at least two haplotypes with frequencies above 25%.
Inference of long-range haplotypes (LRHs) further illustrated the extent of structuring in the TAS2R30 -46 region. Although the 42 SNPs we found could in principle recombine to form millions of LRHs, just 20 were present, and only 5 had frequencies above 0.05. Further, the within-gene haplotypes composing each LRH corresponded exactly to the within-gene haplotypes identified individually, such that each LRH could be described as a composite of five within-gene haplotypes. For example, one LRH was composed of haplotype H1 of TAS2R30, H2 of TAS2R31, H D of TAS2R43, H1 of TAS2R45, and H2 of TAS2R46. For convenience, we named 
Genotype -phenotype associations
Tests for association between SNP alleles and taste responses to saccharin and acesulfame K revealed that 30 of the 42 SNP variants detected in our subjects were significantly (P , 0.001) correlated with both phenotypes, even after correction for multiple testing (Fig. 7A ). The associations were highly similar for both compounds: all variants significantly associated with saccharin response were also significantly associated with response to acesulfame K, and all nonassociated variants were non-associated for both compounds.
Twenty-five of the 30 associated SNPs were non-synonymous, and every gene harbored at least one non-synonymous variant with a significant association. Twenty-three of the associated non-synonymous SNPs encoded amino acid substitutions and two (TAS2R45-A900G/X300W and TAS2R46-G749A/ W250X) encoded premature stops. None of the 42 SNPs observed in our sample was associated with response to salicin or denatonium benzoate. The most conspicuous SNP associations identified in our analyses were between TAS2R43-C104G/S35W, TAS2R31-C103T/R35W and saccharin response. This finding replicates the results of Pronin et al. (29) , and is consistent with prior evidence that both TAS2R31 and -43 are capable of responding to both saccharin and acesulfame K (Fig. 7A) (29) . In addition to replicating previously identified associations between SNPs in TAS2R31 and -43 and saccharin response, we identified numerous associations that have not been previously reported. These included associations between non-synonymous SNPs at all five of the loci we examined, any of which could plausibly alter receptor function. This finding raised the possibility that variants in all five of the genes we examined contribute to variation in saccharin/acesulfame K response. However, this possibility was brought into question by the fact that LD was high (D ′ . 0.95) across the entire TAS2R30 -46 region (Fig. 6 ), which suggested that some of the associations we observed might be due to linkage between non-functional variants and functional variants.
Haplotype association tests clarified the sources of genotype -phenotype associations in our sample. Although TAS2R30 -46 each harbored multiple haplotypes, only one haplotype at each locus was significantly associated with responses to saccharin and acesulfame K: TAS2R30-H1, TAS2R45-H1, TAS2R43-D, TAS2R46-H2 and TAS2R31-H2 (Fig. 7) . No haplotypes were associated with responses to salicin or denatonium benzoate. Tests for association with LRHs revealed that a single allele, LRH11D22, was associated with low threshold response (i.e. high sensitivity) to acesulfame K and saccharin (Fig. 8) . Responses to salicin and denatonium benzoate were not associated with any LRH. Strikingly, LRH11D22 was composed of the five single-gene haplotypes associated with low threshold, which were in tight LD: TAS2R30-H1, TAS2R45-H1, TAS2R43-D, TAS2R46-H2 and TAS2R31-H2 (Figs 7 and 8) .
The association of only LRH11D22 with low threshold responses reduced the number of sites that could account for phenotypic variation in our sample. LRH11D22 was distinguished from non-associated LRHs at just two loci: TAS2R46 and TAS2R31. The other within-gene haplotypes composing LRH11D22, TAS2R30-H1, TAS2R45-H1 and TAS2R43-D were each present in non-associated LRHs (LRH13D33, LRH21111 and LRH11D22, respectively), and thus did not account for significant phenotypic variation. Further, the TAS2R46 allele associated with low threshold, TAS2R46-H2, encodes a premature stop that truncates the receptor by 25%, abolishing receptor function, and is therefore unlikely to cause increased taste sensitivity. Thus, all three sites implicated in conferring low threshold occurred in TAS2R31: TAS2R31-C103T/R35W, TAS2R31-C649G/ Q217E and TAS2R31-C827G/P276R.
To determine the individual contributions of TAS2R31-C103T/R35W, TAS2R31-C649G/Q217E and TAS2R31-C827G/P276R to the association between LRH11D22 and saccharin and acesulfame K thresholds, we performed analyses conditioned on genotype at each position. These analyses revealed that the P-value of association between LRH11D22 and saccharin response increased from highly significant (P ¼ 2.6 × 10
24
) to non-significant levels when conditioned on two of the three sites, TAS2R31-C649G/Q217E and TAS2R31-C827G/P276R, which yielded P-values of 0.07 and 0.11. Thus, these sites were critical to the association of LRH11D22 with saccharin threshold. The P-value of the LRH11D22 association also increased when conditioned on TAS2R31-C103T/R35W, but the increase was smaller (35-fold, from 2.6 × 10 24 to 9.3 × 10
23
) and did not render the LRH11D22 association non-significant. Tests for association with acesulfame K yielded similar results, with conditional for the three sites, respectively. These findings demonstrate that the association between LRH11D22 and phenotypes in our sample is strongly dependent on two variants, TAS2R31-C649G/Q217E and TAS2R31-C827G/P276R, with a third site, TAS2R31-C103T/R35W, making a lesser contribution.
Functional variation
Cell-based assays revealed the functional underpinnings of associations between allelic variation in TAS2R31, TAS2R43 and responses to saccharin and acesulfame K. Assays targeted at each TAS2R31 variant observed in our sample demonstrated that of the seven haplotypes present in our sample only one, TAS2R31-H2, was responsive to saccharin and acesulfame K. This finding supported the results of our association analyses, in which the only LRH associated with threshold responses was LRH11D22, which encodes TAS2R31-H2 (Fig. 9A) . Assays targeted at TAS2R43, which has previously been identified as responsive to saccharin and acesulfame K (22, 28) , confirmed that only TAS2R43-H2 is responsive to saccharin and acesulfame K, and that the response is attenuated relative to that of TAS2R31-H2 (29, 34) .
To establish the functional effects of individual mutations observed in TAS2R31 in our sample, we analyzed artificial chimeric constructs of the receptor. Assays targeted at single mutant variants of the most common TAS2R31 allele, TAS2R31-H1, revealed that only constructs harboring a W at position 35 were responsive to saccharin and acesulfame K (Fig. 9B) . These findings indicated that alteration of this single position was sufficient to abolish receptor function. Moreover, in the absence of W35, no other observed substitution rescued receptor function. This finding is consistent with previous reports that this mutation has important functional effects. Double-mutant assays further established the role of mutations other than R35W in shaping TAS2R31 function. Assays targeted at chimeric variants of TAS2R31-H1 harboring both W35 and a second variant revealed that even when W35 was present, receptor function was severely attenuated or abolished by allelic variants observed at four other sites: H45, F237, R276 and C281 (Fig. 9B) . Thus, these residues, like W35, are essential for receptor function. Introduction of any of them is disabling. This indicates that the genotypephenotype relationships observed in our sample are not a simple one-to-one function of variation in TAS2R31, but a joint function of substitutions at multiple sites.
DISCUSSION
Evidence that genetic variation in TAS2R31 and -43 accounts for variation in the bitter perception of saccharin has suggested that variation in TAS2R30, -45 and -46, which encode alleles responsive to many of the same agonists as TAS2R43 and -31, might affect saccharin response as well (28 -30) . We found that although TAS2R30-46 harbored numerous variants associated with phenotypic responses to saccharin and acesulfame K, these associations arose principally through LD with two functional mutations in TAS2R31, TAS2R31-C649G/ Q217E and TAS2R31-C827G/P276R. Further, in vitro analyses demonstrated that several additional variants present in TAS2R31 are capable of affecting taste response, although their frequencies are low.
A particularly important association in our sample was between variants in TAS2R43 and responses to saccharin and acesulfame K. Previous studies have demonstrated that both TAS2R31 and -43 are capable of responding to saccharin and acesulfame K. In addition, mutational variation in both results in altered receptor response. Our functional analyses recapitulated both of these findings (Fig. 9) . However, genotype -phenotype associations in our sample suggest that TAS2R31 makes a far more important contribution to variable perception of saccharin and acesulfame K than does TAS2R43. While site-by-site analyses detected an association between TAS2R43 variants and response, haplotype analyses revealed that the association was due to LD with functionally relevant sites in TAS2R31. Thus, while TAS2R43 is capable of responding to these compounds, and mutations in TAS2R43 affect functional response, they did not account for significant variance in perception in our sample. This may be due to the weak response of TAS2R43 to saccharin and acesulfame K relative to that of TAS2R31 (Fig. 9) .
Our results also revealed an unexpected layer of complexity in the association between TAS2R31 variants and perception of saccharin and acesulfame K. We found that while associations between TAS2R31 and taste phenotype were driven principally by two sites, several additional polymorphisms in the gene affected receptor function. For instance, amino acid variants observed at four sites were capable of abolishing receptor response altogether. Thus, phenotypic associations arising from variability in TAS2R31 were not simply due to the presence or absence of a single functional variant, but to the joint presence of several alleles, each of which exerts a separate effect. This finding illustrates the potentially varied avenues through which variation in TAS2Rs can exert phenotypic effects. A potentially powerful approach for dissecting these effects would be to examine associations in African populations, which generally exhibit both lower LD and higher diversity than European populations, and hence would provide the opportunity to isolate their contributions.
An important caveat of our findings is that although our results indicate that a large fraction of variance in bitter taste responses to saccharin and acesulfame K is due to variation in TAS2R31, they do not rule out the possibility that genes other than TAS2R31 contribute to bitter perception of saccharin and acesulfame K. In the case of the TAS2R30 -43 subfamily, it could be that certain alleles respond to one or both compounds; however, the patterns of association in our sample indicate that they are either weak or restricted to rare variants. An additional possibility is that genes other than TAS2R30 -46 contribute to variable bitter responses to saccharin and acesulfame K. Variation in genes encoding other parts of the bitter taste transduction pathway, such as G proteins and ion channels, would seem likely to make such contributions. Recently, Fushan et al. (35) demonstrated that variants in GNAT3, which encodes a-gustducin, one of the primary components of the G protein responsible for initiating taste transduction, are associated with perception of sucrose. The participation of a-gustducin in bitter perception suggests that these variants might affect perception of saccharin and acesulfame K, as well.
Similarly, our finding that polymorphism in TAS2R31 is the main source of variation in taste responses to saccharin and acesulfame K does not imply that TAS2R30, -43, -45 and -46 are not important in the perception of other compounds. Although no agonists of TAS2R45 have yet been identified, TAS2R30, -43 and -46 are each capable of responding to multiple compounds (Fig. 1) . For instance, TAS2R46 responds to a variety of common molecules such as caffeine, quinine and hydrocortisone (22) . Further, Reed et al. (36) identified highly significant associations between quinine perception and a cluster of variants centered on TAS2R19 and overlapping TAS2R31. These observations, together with our finding that TAS2R30 -46 are both tightly linked and genetically diverse, suggest that individuals vary in ability to perceive numerous substances as the result of mutations at these loci, and that responses to many compounds will be strongly correlated in spite of the fact that they are mediated by different genes. Further, evidence that taste transduction pathways are active in tissues not involved in perception such as gut, nose and lung cells indicates that variation in these genes could have consequences for physiological responses other than taste.
A particularly important possibility is that copy-number variation occurs at TAS2R loci other than TAS2R43 and -45. Because copy-number variation can result in both overrepresentation and complete absence of expressed proteins, it has the potential to have extreme effects on phenotypes. In the case of TAS2R43 and -45, deletion alleles were obvious because they were present at high frequencies (0.50 and 0.15), resulting in highly abnormal PCR and genotyping results. However, because PCR failures should occur at a rate that is the square of the frequency of the deleted allele, deletions with more modest frequencies will be more difficult to detect. For instance, PCR failure rates with a deletion allele
3446
Human
at a frequency of 0.10 should occur at a rate of ,1%, with less effect on Hardy -Weinberg equilibrium, and hence could be overlooked. Thus, although no sequencing study to date has reported evidence for copy-number variation at other TAS2Rs, such data are highly susceptible to false negatives. Directly characterizing TAS2R loci with respect to copynumber polymorphism will be essential in accurately dissecting genotype -phenotype associations underlying bitter taste responses.
MATERIALS AND METHODS
Subjects
Sixty unrelated Caucasian subjects (41 women, 19 men; age range 20-62 years, mean age 32.3 years, SD ¼ 11.4) were recruited at the German Institute for Human Nutrition (Deutsche Institut für Ernährungsforschung) for phenotyping and genetic analysis. Subjects were pre-screened to avoid inclusion of individuals with overt taste pathologies or other obvious health problems. Each subject participated in the entire course of the study, which required genotyping and eight psychophysical phenotyping sessions.
Tastants
We determined subjects' taste responses to four compounds: acesulfame K, saccharin, salicin and denatonium benzoate (04054, 240931, S0625 and D5765; Sigma-Aldrich, Inc., St Louis, MO, USA). Saccharin has previously been demonstrated to be an agonist of receptors encoded by some alleles of TAS2R31 and -43 (22, 28, 29) . Acesulfame K, like saccharin, is a sulfonamide used as an artificial sweetener and has a bitter aftertaste to some individuals (23) . Acesulfame K is a known agonist of a receptor encoded by at least one allele of TAS2R31 and -43, although it is not known whether taste responses to acesulfame K vary as the result of mutations at these loci (22, 28) . Salicin, a b-glucopyranoside, is structurally unrelated to saccharin and acesulfame K. It is a known agonist of TAS2R16, which is encoded by a locus at chromosome 7q31.1 -7q31.3, and no other receptor (14, 22, 37) . Denatonium benzoate is an agonist for numerous TAS2Rs, but not TAS2R31 or -43 (22) . Thus, salicin and denatonium benzoate provided a basis for comparison and control in our study.
Taste phenotypes
Recognition thresholds were determined for each compound using a modified Harris -Kalmus protocol. In each test, subjects were challenged to identify the bitter aftertaste of a single compound, which was presented in an ascending (doubling) concentration series composed of 10 steps ranging from 1.0 × 10 24 to 5.1 × 10 22 M for saccharin and acesulfame K, eight steps from 2.5 × 10 25 to 3.2 × 10 23 M for salicin and eight steps from 1.3 × 10 25 to 1.6 × 10 27 M for denatonium benzoate. At each step, the subject reported the perceived taste of the solution and spat it out into a supplied container. When a subject proceeding through a series identified a solution as having a bitter taste, the subject was then challenged to sort a set of six cups: three cups containing 20 ml solution at the concentration described as bitter and three cups containing 20 ml solution at the preceding (one step lower) concentration. If the subject successfully sorted the set into two correct groups, that concentration was scored as the recognition threshold. If the subject failed to sort the solutions correctly, the task was repeated at the next (one step higher) concentration. Subjects were then allowed to rinse with water. Each subject evaluated one sweetener and one control substance per session. Four replicates per compound were performed over eight sessions. The sequence in which compounds were tasted was counterbalanced across subjects to avoid presentation-order and carry-over effects. Threshold distributions and cross-compound correlations were calculated based on the mean estimate for each compound within subjects, and log-normal regression analyses were performed with SigmaPlot (Systat Software, Inc., Chicago, IL, USA).
DNA sequencing
Genetic samples were obtained by extracting whole genomic DNA from saliva using PeqLab Blood DNA Kit II (PeqLab Biotechnologie GmbH, Erlangen, Germany). Open reading frames of TAS2R30, -31, -43, -45 and -46 were each sequenced in their entirety ( 1 kb) in all subjects. Some evidence has suggested that an unrelated gene, TAS2R8, may play a peripheral role in taste responses to saccharin (29) . Therefore, this gene was sequenced as well. Primers were designed with the Primer Basic Local Alignment Search Tool (Primer-BLAST) by aligning coding and flanking regions from the human genome reference sequence, and were localized 100 bp upstream or downstream of each gene. PCR was then performed using Advantage 2 Polymerase (Clontech Laboratories Inc., Mountain View, CA, USA) to amplify the full length coding sequence. Size and quality of PCR products were tested with gel electrophoresis. After purification with High Pure PCR Product Purification Kit (F. Hoffmann-La Roche Ltd, Basel, Switzerland), products were sequenced on both strands to obtain sequence of the full coding region.
Copy-number determination
In a genome-wide survey of copy-number variation in the human genome, Sudmant et al. (38) demonstrated the presence of major deletions in the TAS2R30 -46 region, although the exact extent of the deletions was not established. Pronin et al. (29) reported high rates of PCR failure when trying to amplify TAS2R43 and TAS2R45, suggesting that both of these genes are affected, and that the frequency of deletion alleles might be high. To characterize TAS2R30 -46 with respect to putative copy-number variants, we used ABI TaqMan Gene Copy Number Assays. These assays used realtime amplification of fluorescently labeled probes to determine the ratio of the quantity of a target product (here, TAS2R30 -46) to the quantity of a stable control product (RNaseP). To ensure that sequences obtained from each gene represented a single locus, and not a composite of more than one, we targeted probes at regions constant across sequence reads for each gene in subjects but otherwise unique in the genome. This guaranteed that probes would detect all gene copies represented by the reads for each gene without spuriously Human Molecular Genetics, 2011, Vol. 20, No. 17 3447 reporting other loci. Assay results revealed whether a given sample contains zero copy of a particular gene (i.e. is homozygous for the deletion), one copy (heterozygous for the deletion) or two copies (does not carry the deletion). We designed assays targeting each gene in our study (TAS2R30 -46), which we used to determine copy number in all subjects.
Genotype calling
Genotypes were called by combining raw DNA sequencing results and copy-number data. Genotypes at TAS2R30, -31 and -46, which showed no evidence of copy-number variation, were called based on sequencing data alone. Genotypes at TAS2R43 and -45 could not be called on the basis of raw sequencing data due to ambiguity caused by the presence of deletion (D) alleles. Because D alleles fail to amplify in PCR and sequencing reactions, individuals heterozygous for D alleles will appear to be homozygous with respect to all SNP positions. For example, in the case of a subject appearing to be homozygous with respect to a particular SNP (e.g. CC), it could not be determined whether the genotype was truly CC or was actually CD, because they appear identical on sequencing chromatograms. Information on copy number resolved this problem by enabling us to distinguish true homozygotes for a particular SNP allele (which had a copy number of two) from those carrying one copy of the SNP allele and one deleted allele (which had a copy number of one) as well as homozygotes for the D allele (which had a copy number of zero). Thus, genotypes in TAS2R43 and -45 were called with respect to three alleles (two SNP alleles and a deletion allele).
Haplotype estimation
DNA sequence data enabled us to identify most haplotypes unambiguously in subjects with zero or one variable nucleotide positions, which indicated the presence of one or two haplotypes, respectively. Subcloning from additional samples identified the remaining haplotypes. LRHs, spanning the entire 140 kb TAS2R30-46 region, were inferred by analyzing variation in all five genes simultaneously using the PHASE computer program, which examines genotypes to determine the most likely configuration of alleles along a chromosome and their allocation among individuals (39) .
Linkage disequilibrium
LD among markers was determined using two measures, D ′ and r 2 (40) . These measures were used to test for correlations among each pair of SNPs identified in genotyping. In the case of TAS2R43 and TAS2R45, all SNPs were triallelic, with two nucleotide alleles and a deletion allele. Therefore, these SNPs were recoded as diallelic markers by collapsing the two more weakly associated alleles identified in SNP-by-SNP association analyses into an aggregate class. LD calculations were performed using the genetics module of the R statistical analysis software package (41, 42) .
Association analyses
SNP-by-SNP genotype-phenotype associations were tested using the regression models in the R statistical analysis package (41) . Tests for overall gene-specific and cross-gene effects were performed under mixed models for repeated measures with SAS (SAS Institute Inc., Cary, NC, USA), treating genotype as independent variable and log-transformed thresholds as dependent variables. Similarly, haplotype-specific and cross-gene effects were performed treating haplotypecarrier status as an independent variable, and only haplotypes with frequencies .0.05 were included in these analyses.
Functional assays
The functional characteristics of individual receptor alleles were determined using heterologous expression and calcium imaging assays developed in the course of previous studies (22) . Receptor variants were amplified from genotyped DNA samples and subcloned into the pcDNA5/FRT/TO expression vector (Invitrogen, Carlsbad, CA, USA), which was appended with an N-terminal plasma membrane-targeting sequence consisting of the amino acids 1 -45 of the rat somatostatin type 3 receptor to ensure cell-surface localization which the C-terminal HSV tag was omitted. Additional constructs, composed of single-and double-point mutations introduced to target alleles, were generated using the QuickChange protocol (Stratagene, Inc., La Jolla, CA, USA) according to the manufacturers' recommendations. The correctness of all constructs was checked prior to functional analysis by sequencing.
Functional expression analyses were carried out in a HEK293-Flp-In T-REx cell line (Invitrogen) stably expressing human phospholipase-C-b2 (PLCb2) under control of an inducible tetracycline promoter. Each construct was transiently co-transfected with PLCb2 and the G protein subunits, a-gustducin, b-3 and g-13 in equal amounts, to enable correct signaling. Empty pcDNA5/FRT vector was used as negative control. Twenty-four to 32 h post transfection and induction of PLCb2 expression, calcium imaging was performed by exposing transfected cells to solutions of saccharin (5 mM), acesulfame K (5 mM) dissolved in C1 solution (130 mM NaCl, 5 mM KCl, 10 mM HEPES, 2 mM CaCl 2 and 1 mM glucose, pH 7.4), and recording responses with an automated fluorometric imaging plate reader (Molecular Devices, Inc., Sunnyvale, CA, USA). Following exposure, cell vitality was verified by applying 100 nM endogenous somatostatin receptor type 2 (Bachem AG, Bubendorf, Switzerland). Dose-response data were collected from a minimum of three independent experiments, which were performed at least in duplicate. Peak fluorescence responses after exposure were normalized to background fluorescence (DF/ F ¼ (F-F0)/F0) and baseline noise was subtracted.
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